Institutional investors purchased a net $1.8 million shares of MBIO during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 28.64% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ENVESTNET ASSET MANAGEMENT, INC. Bought 1.9 Thousand shares of Mustang Bio Inc
DAVENPORT & CO. LLC Sold 350.00 shares of Mustang Bio Inc